Cat. #153819
Anti-eAg Antibody from X63 Fused CD19 B Cell Hybridoma (F8)
Cat. #: 153819
Unit size: 100 ug
Availability: 3-4 weeks
Target: Enteroantigen
Class: Monoclonal
£300.00
This fee is applicable only for non-profit organisations. If you are a for-profit organisation or a researcher working on commercially-sponsored academic research, you will need to contact our licensing team for a commercial use license.
Contributor
Inventor: Anders Elm Pedersen ; Mogens H Claesson
Institute: University of Copenhagen
Tool Details
*FOR RESEARCH USE ONLY (for other uses, please contact the licensing team)
- Name: Anti-eAg Antibody from X63 Fused CD19 B Cell Hybridoma (F8)
- Research fields: Other
- Clone: F8
- Class: Monoclonal
- Conjugation: Unconjugated
- Description: Regulatory B cells (Bregs) have been shown to play a role in inflammatory bowel disease (IBD) in humans, as B cell depletion in patients with IBD tends to aggravate the disease. Furthermore it has been demonstrated that co-transfer of eAg-exposed B cells improves symptoms of experimental colitis in the T cell transfer model of colitis. This eAg-specific B cell hybridoma offers a unique tool to investigate the immune response towards eAgÄËĂÂĂÂs in experimental colitis, and potentially,...
Target Details
- Target: Enteroantigen
- Target background: Regulatory B cells (Bregs) have been shown to play a role in inflammatory bowel disease (IBD) in humans, as B cell depletion in patients with IBD tends to aggravate the disease. Furthermore it has been demonstrated that co-transfer of eAg-exposed B cells improves symptoms of experimental colitis in the T cell transfer model of colitis. This eAg-specific B cell hybridoma offers a unique tool to investigate the immune response towards eAgÄËĂÂĂÂs in experimental colitis, and potentially,...
Handling
- Format: Liquid
- Concentration: 0.9-1.1mg/ml
- Unit size: 100 ug
- Storage buffer: PBS with 0.02% azide
- Storage conditions: -15° C to -25° C
- Shipping conditions: Shipping at 4° C
References
- In vitro cloning and regulatory potential of B cell hybridomas secreting entero-antigen specific antibody.
